<DOC>
	<DOCNO>NCT02708901</DOCNO>
	<brief_summary>The purpose study assess effect 6-months supplementation probiotic Vivomixx® inflammatory gastrointestinal ( GI ) biomarkers , gastrointestinal disturbance , behavioral developmental profile , neurophysiological feature preschooler Autism Spectrum Disorders ( ASD ) without GI symptom .</brief_summary>
	<brief_title>Gut Brain Interaction Autism . Role Probiotics Clinical , Biochemical Neurophysiological Parameters</brief_title>
	<detailed_description>Autism Spectrum Disorders ( ASD ) likely multifactorial disease combination genetic environmental factor might role expression phenotype . A high incidence gastrointestinal ( GI ) symptom report ASD . GI disturbance alter gut microflora could make child genetic predisposition ASD prone express ASD phenotype increase severity behavioral symptom . The exploitation strategy reduce gut production absorption toxins restore normal gut microbiota , probiotic may represent non-pharmacological option treatment GI disturbances ASD . The aim study determine effect probiotic supplementation Vivomixx® ASD child specific GI symptom , ASD core deficit , cognitive language development , inflammatory gastrointestinal ( GI ) biomarkers Quantitative Electroencephalographic measure ( QEEG ) . Vivomixx® probiotic mixture 8 probiotic strain ( Bifidobacterium breve , Bifidobacterium longum , Bifidobacterium infantis , Lactobacillus acidophilus , Lactobacillus plantarum , Lactobacillus paracasei , Lactobacillus bulgaricus Streptococcus thermophilus ) . An additional aim study determine environmental exposure phthalates ( chemical pollutant ) ASD child , possible effect probiotic supplementation urinary concentration . A group 100 unselected preschooler ASD classify belong Gastro Intestinal ( GI ) group Not Gastro Intestinal ( NGI ) group basis presence significant GI symptom GI severity Index . Subjects belong two group ( GI NGI ) blind randomized 1:1 regular diet probiotic Vivomixx® placebo 6 month . All participant assess baseline , three month six month baseline order evaluate possible change GI symptom , ASD symptomatology , affective behavioral comorbid symptom , plasmatic , urinary fecal biomarkers relate abnormal intestinal function electrophysiological pattern . The effect treatment probiotic child ASD need confirm rigorous control trial . Aiming examine impact treatment clinical also neurophysiological pattern trial set provide new insight gut-brain connection autism . Moreover , study 's result could add new data relationship presence phthalates , clinical feature neurophysiological pattern ASD .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<criteria>agerange : 1872 month ASD diagnosis accord Diagnostic Statistical Manual Mental Disorders5 ( DSM5 ) criteria brain anomaly detect Magnetic Resonance Imaging ( MRI ) neurological syndrome focal neurological sign anamnesis birth asphyxia , severe premature birth ( ≤ 28 gestational week ) perinatal injury epilepsy significant sensory impairment diagnosis organic GI Disorder ( i.e . gastroesophageal reflux , food allergy , Inflammatory Bowel Disease ) diagnosis Coeliac Disease special diet ( i.e . glutenfree diet , caseinfree diet , highprotein diet , ketogenic diet )</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>72 Months</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Autism Spectrum Disorder</keyword>
	<keyword>Probiotic Vivomixx®</keyword>
	<keyword>Gastrointestinal Symptoms</keyword>
	<keyword>Gut-Brain Axis</keyword>
	<keyword>Endophenotypes</keyword>
</DOC>